Publications

Justices Urged To Clarify Patent Validity In Entresto Case

Quoted, Law360

Hatch-Waxman & Biologics Chair Chad Landmon discusses a U.S. Supreme Court case involving Novartis’ heart drug, Entresto, that could affect how patents are interpreted in the U.S.